news
Corona
"Seeing the end of the epidemic": Who is Pfizer's drug against Corona intended for and how much will treatment cost
The drug, "Paxlovid", will be on the market in a few months after it passes FDA approval.
It will initially be intended for at-risk individuals and adults over the age of 60. It will be taken by patients with symptoms with an estimated cost of treatment of about $ 700.
In the US, millions of dishes have already been promised: "Another tool in the toolbox"
Tags
Corona virus
Pfizer
News agencies
Friday, 05 November 2021, 18:23 Updated: 18:35
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments
The new drug against the corona virus whose efficacy was announced today (Friday) Pfizer may only hit the market in a few months, but there are already some in the world who are praising it on the assumption that it will be approved by the FDA and even "put an end" to the epidemic.
So who exactly is the antiviral drug for and how much will it cost to treat it?
These are the details.
The drug, to be called Paxlovid, has been found to be 89% effective in reducing the risk of hospitalization and death as a result of virus infection and the pills are intended for patients at high risk, adults over 60, immunosuppressed and people with medically sensitive respiratory conditions such as people with extreme obesity.
The total cost of treatment with the new drug is estimated at about $ 700.
More on Walla!
Pfizer: Our anti-corona drug is 89% effective in preventing serious illness and death
To the full article
Pfizer plant in Belgium (Photo: AP, AP)
This is the second drug developed against a disease caused by the corona virus.
Merck announced in September that the drug it had developed, molnupiravir, was 50% effective in reducing deaths and requiring hospitalization.
However, experts testified that the success rates of the two companies should not be compared due to differences between the studies.
Research data
Data collected from 1,200 subjects from several countries
Some of the patients were treated with the drug and some with a placebo
All subjects were not vaccinated for Corona
Only 0.8% of those who took the drug were required to be hospitalized
Deaths were recorded only among subjects who took a placebo
The two companies have announced that they have already started producing the drugs and that they plan to increase production over the next year.
A U.S. administration official said the administration was negotiating with Pfizer for the supply of pills for 1.7 million treatment sets, with the possibility of further increasing the scope of supply to 3.3 million.
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments